FDA Inspection
Glaxo Operations U.K. Ltd.Glaxo Operations U.K. Ltd. – FDA Inspection, Mar 16, 2023
Record Details
This FDA Inspection record concerns Glaxo Operations U.K. Ltd., with an inspection on March 16, 2023, issued by the Office of Inspections and Investigations.
- Company
- Glaxo Operations U.K. Ltd.
- Inspection Date
- March 16, 2023
View Company Profile
ID · beeed03d-92cd-4f68-97d4-c6f9a9109c7f
Inspection Facts
- Inspection number
- 1211398
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Glaxo Operations U.K. Ltd.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| February 10, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2019 | VAI | Office of Inspections and Investigations | New Drug Evaluation |
| July 4, 2017 | Not classified | Office of Inspections and Investigations | |
| June 2, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Glaxo Operations U.K. Ltd.
- FDA Inspection 1209851 - 2023-02-10
- FDA Inspection 1107134 - 2019-09-17
- FDA Inspection 1016930 - 2017-07-04
- FDA Inspection 1014765 - 2017-06-02
- FDA Inspection 933676 - 2015-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.